#organon-co
LightNews LightNews
eigenvectrix.northsky.social
ARTG HRT product sponsors with US parent companies:
Clinect (Testavan) — Blackfriars Corp
J&J Pacific (Motilium) — Johnson & Johnson
Organon Pharma (Propecia, Proscar) — Organon & Co
Pfizer Australia (Aldactone, Provera) — Pfizer Inc
Alphapharm (Cosamide, Cyprone, Spiractin) — Viatris
April 24, 2025 at 9:16 PM
eigenvectrix.northsky.social
Organon & Co — via Organon Pharma Pty Ltd
* Propecia (finasteride)
* Proscar (finasteride)
April 25, 2025 at 9:34 AM
cnbc.com
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
To fuel its global ambitions, Sun Pharmaceutical Industries plans to acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.
cnb.cx
April 27, 2026 at 2:16 AM
reuters.com
India's Sun Pharma to buy Organon in $11.75 billion all-cash deal reut.rs/42uBRan
India's Sun Pharma to buy Organon in $11.75 billion all-cash deal
India's ​Sun Pharmaceutical Industries will ‌buy Organon & Co in an all‑cash deal, ​valuing the U.S. ​drugmaker at about $11.75 billion ⁠including debt, the companies ​said on Sunday.
reut.rs
April 27, 2026 at 12:30 AM
ad-hoc-news.de.web.brid.gy
Organon & Co Aktie: NDUVRA kommt in Kanada auf den Markt
Sun Pharma will rund 100 Milliarden Rupien über Schuldpapiere aufnehmen; Organon Canada meldet die Zulassung von NDUVRA.
www.ad-hoc-news.de
October 1, 2026 at 1:44 PM
newsguy.bsky.social
India's Sun Pharmaceuticals announces $12 billion acquisition of debt-ridden New Jersey-based Organon, a Merck spinoff focused on women's healthcare and biosimilars. m.economictimes.com/markets/s...
Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisition
Sun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in women's health. This strategic move aims to bolster Sun Pharma's innovative medicines business and establish it as a top-tier player in biosimilars and women's health globally.
m.economictimes.com
April 27, 2026 at 11:35 AM
cerebrodigital.net
¿Sabías que esta adquisición convierte a Sun Pharma en una de las 25 farmacéuticas más grandes del mundo? Con ingresos combinados de $12.400 millones, este movimiento podría cambiar el panorama de la industria. ¿Qué implicaciones tendrá para el...
Sun Pharma compra Organon por $11.750 millones: la mayor adquisicion farmaceutica india en la historia - Sinaptica
Sun Pharmaceutical Industries anuncio el 27 de abril de 2026 un acuerdo definitivo para adquirir Organon & Co. (NYSE: OGN) por $14,00 por accion en efectivo
sinapti.ca
April 28, 2026 at 1:12 AM
forbes.com
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
With the purchase of Organon & Co., billionaire Dilip Shanghvi's Sun Pharmaceutical Industries' annual revenue will more than double to $12.4 billion and make it one of the world’s top 25 drugmakers.
www.forbes.com
April 27, 2026 at 2:29 PM
microtech.bsky.social
Action collective envisagée contre Organon & Co. pour fraude présumée sur les titres. Investisseurs concernés, soyez vigilants ! Plus d'infos sur prnewswire.com. ActionCollective #Investisseurs #Organon #Fraude #Titres #Finance #Bourse #Alerte Link
July 7, 2025 at 12:27 AM
narrowit.bsky.social
New House STOCK Act disclosure: Kevin Hern reported a sale of 2000166537JT Organon & Co. Common Stock (OGN) [ST]. Amount: $1,001 - $15,000. Transaction date: 2026-08-05. Filed:...

https://www.narrowit.com/politics-trading/ea22b34c6013f2d79eed
#CongressTrading #StockAct #House #OGN #HousePtr
Kevin Hern Sale Disclosure - 2000166537JT Organon & Co. Common Stock (OGN) [ST] | Narrowit.com
Kevin Hern filed a House STOCK Act disclosure reporting a sale of 2000166537JT Organon & Co. Common Stock (OGN) [ST]. Amount: $1,001 - $15,000. Transaction date: 2026-08-05. Filed: 2026-08-12.
www.narrowit.com
August 13, 2026 at 6:31 PM
narrowit.bsky.social
New House STOCK Act disclosure: Kevin Hern reported a sale of JT Organon & Co. Common Stock (OGN) [ST]. Amount: $1,001 - $15,000. Transaction date: 2026-08-05. Filed: 2026-08-10....

https://www.narrowit.com/politics-trading/a328f80647a31f79dd9f
#CongressTrading #StockAct #House #OGN #HousePtr
Kevin Hern Sale Disclosure - JT Organon & Co. Common Stock (OGN) [ST] | Narrowit.com
Kevin Hern filed a House STOCK Act disclosure reporting a sale of JT Organon & Co. Common Stock (OGN) [ST]. Amount: $1,001 - $15,000. Transaction date: 2026-08-05. Filed: 2026-08-10.
www.narrowit.com
August 12, 2026 at 12:33 AM
megabottest.bsky.social
Sun Pharmaceutical to acquire Organon and Co. for 11.75 billion dollars. DARPA seeks compact autonomous deep ocean craft. The White House website removed references to Arab American Heritage Month. Gabrielle Harrington faces murder charges after a fatal collision in London.
April 27, 2026 at 12:59 AM
dineroenusa.com
3/ 📉 PERDEDORAS

Intellia Th.: -6% al pausar un estudio clave por toxicidad en un paciente $NTLA

Organon & Co.: -6% tras la renuncia del CEO por una investigación de ventas "impropias" $OGN

Carter's Inc.: -4% por malos ingresos del Q3 y anunciar recortes de personal $CRI
October 28, 2025 at 8:41 PM
uswatch.nzcow.com
【美国观察：印度药业巨头 Sun Pharma 117.5 亿美元收购美国 Organon】CNBC 报道，印度最大的药企 Sun Pharma 将以全现金方式收购总部位于新泽西的 Organon & Co，交易估值达 117.5 亿美元。这标志着印度药企在美市场从单纯的“廉价替代品”供应商转向通过大规模并购掌握核心资产。Organon 在女性健康和生物类似药领域有深厚积淀，此次收购将极大地提升 Sun Pharma 的全球议价能力。后续需关注 FTC 的反垄断审查及是否会引发其他药企的防御性并购。 #美国观察 #美国市场 #医药行业 #SunPharma #并购 #CNBC
April 27, 2026 at 6:02 AM
yourdigitalbrain.bsky.social
Did you know that this deal marks a 103% premium over Organon's stock price just weeks ago? With this acquisition, Sun Pharma is set to join the ranks of global pharmaceutical giants. What could this mean for the industry? 💊
Sun Pharma acquires Organon for $11.75 billion: the largest Indian pharmaceutical acquisition in history - Sinaptica
Sun Pharmaceutical Industries announced on April 27, 2026, a definitive agreement to acquire Organon & Co. (NYSE: OGN) for $14.00 per share in cash, which i
sinapti.ca
April 28, 2026 at 1:12 AM
mgstocks.bsky.social
💊 Sun Pharma's $11.75 Billion

Sun Pharmaceutical Industries reported a 27% profit rise. Net profit reached 28.95 billion rupees, up from 22.79 billion a year earlier. The company will buy Organon & Co for $11.75 billion.

https://finance.yahoo.com/healthcare/articles/indias-sun-pharma-posts-higher
August 14, 2026 at 5:35 PM
mgstocks.bsky.social
📈 Sun Pharma's Profit Rise

Sun Pharmaceutical Industries saw a 27% profit rise. Net profit hit 28.95 billion rupees, up from 22.79 billion last year. The firm plans to acquire Organon & Co for $11.75 billion.

https://finance.yahoo.com/healthcare/articles/indias-sun-pharma-posts-higher-090749675.h
August 13, 2026 at 7:20 PM
mgstocks.bsky.social
📈 Sun Pharma's $11.75 Billion

Sun Pharmaceutical Industries reported a 27% profit rise. Its net profit reached 28.95 billion rupees, up from 22.79 billion a year ago. The company will buy Organon & Co for $11.75 billion.

https://finance.yahoo.com/healthcare/articles/indias-sun-pharma-posts-higher
August 13, 2026 at 12:50 PM
mgstocks.bsky.social
📈 Sun Pharma's $11.75 Billion

Sun Pharmaceutical Industries reported a 27% profit rise. Consolidated net profit reached 28.95 billion rupees, up from 22.79 billion. The company will acquire Organon & Co for $11.75 billion.

https://finance.yahoo.com/healthcare/articles/indias-sun-pharma-posts-high
August 12, 2026 at 6:30 PM
mgstocks.bsky.social
💊 Sun Pharma's $11.75 Billion

Sun Pharmaceutical Industries reported a 27% profit rise. Its net profit reached 28.95 billion rupees, up from 22.79 billion. The company will acquire Organon & Co for $11.75 billion.

https://finance.yahoo.com/healthcare/articles/indias-sun-pharma-posts-higher-090749
August 8, 2026 at 9:15 PM
vaultlynews.bsky.social
Organon Misses Earnings by $0.50: What It Means for Healthcare ETFs
Score 7/10 · Medium · 3 days
Organon Misses Earnings by $0.50: What It Means for Healthcare ETFs
Score 7/10 · Impatto: Medium · Finestra: 3 days Asset: Organon Co, OGN, healthcare ETFs, dividend ETFs Organon's earnings miss of $0.50 and revenue shortfall could trigger downward pressure on healthcare and dividend-focused ETFs holding the stock.
vaultly-omega.vercel.app
August 2, 2026 at 6:15 AM
quant-hub.bsky.social
🚨 $OGN
A special meeting of stockholders of Organon & Co., a Delaware corporation , was held on July 23, 2026 at 10:00 a.m., Eastern Time, via a virtual meeting website.
SEC Filing: OGN
Click to view the official SEC document.
www.sec.gov
July 23, 2026 at 9:23 PM
quant-hub.bsky.social
🚨 $OGN
A special meeting of stockholders of Organon & Co., a Delaware corporation , was held on July 23, 2026 at 10:00 a.m., Eastern Time, via a virtual meeting website.
SEC Filing: OGN
Click to view the official SEC document.
www.sec.gov
July 23, 2026 at 9:23 PM
quant-hub.bsky.social
🚨 $OGN
As previously disclosed, on April 26, 2026, Organon & Co., a Delaware corporation , entered into an Agreement and Plan of Merger by and among the Company, Sun Pharmaceutical Holdings USA, Inc. , and Sun Pharma America, Inc., a wholly owned subsidiary of Sun Pharma USA , and, solely for pur...
SEC Filing: OGN
Click to view the official SEC document.
www.sec.gov
July 17, 2026 at 8:06 PM
marketcompiler.bsky.social
$OGN: Organon & Co. (NYSE:OGN) JPMorgan Healthcare Conference Call on Jan 13, 2025 at 6:45 PM ET with CEO Kevin Ali and CFO Matthew Walsh.
seekingalpha.com/article/4749...
Organon & Co. (OGN) JPMorgan Annual Healthcare Conference (Transcript)
Call Start: 18:45 January 1, 0000 7:23 PM ETOrganon & Co.
seekingalpha.com
July 19, 2025 at 4:01 PM